BACKGROUND: Potential for difficult reoperations has been a concern for patients undergoing a Ross procedure. Data regarding the outcomes of such reoperations is extremely limited. We examined our experience to define the current scope and risk of these operations. METHODS: Between 1996 and 2020, 83 patients who had a previous Ross procedure underwent 89 reoperative surgeries. There were 72 males and average age was 48 with a range of 18-76. Twenty-four patients had more than one prior reoperation, with five patients having more than one reoperation post Ross. Patients were stratified by primary reason for reoperation including autograft dysfunction, homograft dysfunction, or other cardiac surgical problems. Demographic, operative, and outcomes data were collected from clinical records and placed in a secure data base for analysis. RESULTS: A total of 176 procedures were done in the 89 operations. Autograft dysfunction affected 68 patients. Homograft dysfunction affected 27 patients. Both of these were seen in 17 patients. Other cardiac problems required 79 other procedures. There were two (2.2%) operative deaths, with perioperative morbidity affecting six patients (6.7%). Survival following reoperation after Ross was 82.3% and 77.5% (±2), at ten and fifteen years respectively. CONCLUSIONS: Reoperations after a Ross procedure can be challenging but can be done with a high degree of safety and long-term benefit in experienced hands. 2021 Annals of Cardiothoracic Surgery. All rights reserved.
BACKGROUND: Potential for difficult reoperations has been a concern for patients undergoing a Ross procedure. Data regarding the outcomes of such reoperations is extremely limited. We examined our experience to define the current scope and risk of these operations. METHODS: Between 1996 and 2020, 83 patients who had a previous Ross procedure underwent 89 reoperative surgeries. There were 72 males and average age was 48 with a range of 18-76. Twenty-four patients had more than one prior reoperation, with five patients having more than one reoperation post Ross. Patients were stratified by primary reason for reoperation including autograft dysfunction, homograft dysfunction, or other cardiac surgical problems. Demographic, operative, and outcomes data were collected from clinical records and placed in a secure data base for analysis. RESULTS: A total of 176 procedures were done in the 89 operations. Autograft dysfunction affected 68 patients. Homograft dysfunction affected 27 patients. Both of these were seen in 17 patients. Other cardiac problems required 79 other procedures. There were two (2.2%) operative deaths, with perioperative morbidity affecting six patients (6.7%). Survival following reoperation after Ross was 82.3% and 77.5% (±2), at ten and fifteen years respectively. CONCLUSIONS: Reoperations after a Ross procedure can be challenging but can be done with a high degree of safety and long-term benefit in experienced hands. 2021 Annals of Cardiothoracic Surgery. All rights reserved.
Entities:
Keywords:
Ross procedure; aortic root replacement; pulmonary autograft; reoperation; valve surgery
Authors: J A Bekkers; L M A Klieverik; G Bol Raap; J J M Takkenberg; A J J C Bogers Journal: J Thorac Cardiovasc Surg Date: 2010-12 Impact factor: 5.209
Authors: Amine Mazine; Rodolfo V Rocha; Ismail El-Hamamsy; Maral Ouzounian; Bobby Yanagawa; Deepak L Bhatt; Subodh Verma; Jan O Friedrich Journal: JAMA Cardiol Date: 2018-10-01 Impact factor: 14.676
Authors: Aart Mookhoek; Laurent de Kerchove; Gebrine El Khoury; Timo Weimar; Giovanni Battista Luciani; Alessandro Mazzucco; Ad J J C Bogers; Diana Aicher; Hans-Joachim Schäfers; Efstratios I Charitos; Ulrich Stierle; Johanna J M Takkenberg Journal: J Thorac Cardiovasc Surg Date: 2015-08-15 Impact factor: 5.209
Authors: Elisabeth Martin; Siamak Mohammadi; Frederic Jacques; Dimitri Kalavrouziotis; Pierre Voisine; Daniel Doyle; Jean Perron Journal: J Am Coll Cardiol Date: 2017-10-10 Impact factor: 24.094
Authors: Edward Buratto; William Y Shi; Rochelle Wynne; Chin L Poh; Marco Larobina; Michael O'Keefe; John Goldblatt; James Tatoulis; Peter D Skillington Journal: J Am Coll Cardiol Date: 2018-03-27 Impact factor: 24.094
Authors: John M Stulak; Harold M Burkhart; Thoralf M Sundt; Heidi M Connolly; Rakesh M Suri; Hartzell V Schaff; Joseph A Dearani Journal: Circulation Date: 2010-09-07 Impact factor: 29.690